4d
GlobalData on MSNMSD commences Phase III trial of DLBCL treatmentMSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...
4d
GlobalData on MSNReplicate’s rabies vaccine rivals Bavarian Nordic’s RavAlert at Phase IThe US company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.
Clinical trials can assist you in getting the right treatment for your condition. Before you consider it, here's what you should know.
As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...
Fortunately, we are making some progress as organizations such as the Partnership for Advancing Clinical Trials (PACT) ...
Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...
Universities are scrambling after the National Institutes of Health announced a plan to cut millions of dollars in research funding under the Trump administration.
5d
GlobalData on MSNAnnovis begins treatment of subjects in Alzheimer’s trialAnnovis Bio has commenced the treatment of subjects in a Phase III clinical trial of buntanetap in treating early Alzheimer's ...
After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...
The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...
Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...
AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim d ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results